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PARENTS OF ASTHMATIC CHILDREN WERE ACCURATE
REPORTERS OF URGENT HEALTH SERVICES USE—
A RETROSPECTIVE AGREEMENT ANALYSIS
Ungar WJ1, Davidson-Grimwood SR1, Cousins M2
1The Hospital for Sick Children,Toronto, ON, Canada, 2McMaster
University, Hamilton, ON, Canada
OBJECTIVES: While parents are frequently relied upon to
report their children’s health services use for epidemiological and
health economic evaluations, the accuracy of parental proxy
reports remains unknown. The objective was to assess agreement
between parents’ proxy reports of children’s respiratory-related
health service use and administrative data in a sample of pedi-
atric asthma patients. METHODS: A retrospective analysis of
statistical agreement between clinical and claims data for reports
of outpatient physician visits, Emergency Department (ED) visits
and hospitalizations was conducted for 545 asthmatic children
recruited from urban and suburban clinics and ED sites in the
greater Toronto area. Health services use data were extracted
from the Ontario Health Insurance Plan and Canadian Institute
for Health Information administrative databases for each child
for the interval coinciding with the proxy report for each type
of health service. RESULTS: Agreement between administrative
data and respondent reports was substantial for inpatient admis-
sions (κ = 0.80, 95% CI 0.74, 0.86) in the past year, moderate
for ED visits (κ = 0.60, 95% CI 0.53, 0.67) in the past year and
poor for outpatient physician visits (κ = 0.13, 95% CI 0.00,
0.27) in the past 6 months. Income, parent’s education and child
quality of life symptom scores did not affect agreement. Agree-
ment for ED visits was signiﬁcantly higher (p < 0.05) for chil-
dren that had an asthma attack in the past 6 months (κ = 0.61,
95% CI 0.54, 0.68) compared to children that did not (κ = 0.25,
95% CI 0.00, 0.59). CONCLUSION: Parents of asthmatic chil-
dren are good proxy reporters of their child’s respiratory-related
health services utilization for ED visits and inpatient admissions.
Parent proxy reports of urgent care, important markers of
asthma morbidity, can be used reliably in epidemiological and
health economic studies.
ALLERGY/ASTHMA—Methods & Concepts
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DATA EXTRACTION METHODS, ECONOMETRIC MODELING
AND FACTORIAL ANALYSIS REVEAL CLINICALLY
IMPORTANT PATIENT PROFILES IN CHRONIC ASTHMA
Reissell E1, Palmu PJ1, Schultz J1, Pirskanen A1, Salonoja M1,
Kunnas T1, Sintonen H2, Haahtela T3,Tukiainen P3, Lindqvist A3,
Laitinen T1
1GeneOS Ltd, Helsinki, Finland, 2University of Helsinki, Helsinki,
Finland, 3Helsinki University Hospital, Helsinki, Finland
OBJECTIVES: To evaluate the clinical factors contributing to the
severity of chronic asthma. METHODS: A total of 1860 patients
with chronic pulmonary disease were invited to the study and
comprehensive 10 yr medical history was collected for every par-
ticipant from their health care providers. Data included all
recorded symptoms, signs, adverse drug effects, diagnostic test
results, treatments, and procedures. The data were converted
into electronic format and advanced text-information extraction
methods were used to measure contact-by-contact all cost related
and clinical attributes. We developed a medication independent
score for the stability of asthma, allergies and other pertinent
entities and applied a fuzzy classiﬁcation rule by disease speciﬁc
variables to determine the respective costs. Individual-periodic
variation in the cost of care was modeled by econometric
methods. A multidimensional correspondence analysis (MCA)
was used to distinguish meaningful patient clusters wihin the cost
context. RESULTS: Of 230,000 health care contacts analyzed,
approximately 35% were identiﬁed as asthma-related. The
average cost of annual asthma care excluding medication and
indirect costs was 520€. Hospitalizations and urgent visits
explained a signiﬁcant part of the high expenses. Two distinct
patient cohorts were identiﬁed with the MCA, an elderly cohort
with signiﬁcant co-morbidities and a younger with preponder-
ance toward infectious and allergic symptoms and ﬁndings.
These altogether 16% of patients explained 81% of the total
costs of care for asthma in our study. CONCLUSION: This real
world data on health care utilization can be used to identify dif-
ferent patient proﬁles, a prerequisite for individualized health
care interventions.
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THE EVOLUTION OF ASTHMA GUIDELINES FOR CHILDREN
Cope SF1, Ungar WJ2, Glazier RH3, Kozyrskyj A4, Paterson M3
1University of Toronto,Toronto, ON, Canada, 2The Hospital for Sick
Children,Toronto, ON, Canada, 3Institute for Clinical Evaluative
Sciences,Toronto, ON, Canada, 4Manitoba Centre for Health Policy,
University of Manitoba, Winnipeg, MB, Canada
OBJECTIVES: To depict the evolution of pediatric guidelines for
asthma and to compare the current guidelines internationally in
terms of their organization, presentation of evidence, and special
consideration for children, especially with respect to the deﬁni-
tions of asthma control and severity. METHODS: A systematic
search to identify asthma guidelines was conducted. All of the
guidelines were organized in chronological order by country and
searched for the terms “pediatric,” “child,” or “age.” Any con-
siderations speciﬁc to pediatric asthma incorporated into the 
recommendations were summarized. The concepts of asthma
control and severity were reviewed in the literature and their def-
initions were compared across the most current guidelines.
RESULTS: The most prominent pediatric asthma guidelines 
that have been put forward were by the Global Initiative for
Asthma (GINA), Canada, and Japan. United States, Britain, and
Australia have adopted additional chapters for children or
updated their guidelines to reﬂect literature speciﬁc to children.
Current guidelines consistently address pediatric aspects of the
asthma diagnosis, prevention, pharmacotherapy, inhalation
devices, and management for acute exacerbations. However,
none of the guidelines deal with the challenges of assessing
asthma control or severity in children. The parameters used to
measure asthma control and severity are not consistent across
the guidelines and their relevance in children has not been clearly
established. CONCLUSION: There has been signiﬁcant progress
away from consensus opinion towards evidence-based guidelines
for asthma. Pediatric considerations in the management of
asthma have been integrated into guidelines in different coun-
tries to different degrees and through varied strategies. It will be
important for future guidelines to clearly present the diverse
challenges associated with pediatric asthma management in a
way that identiﬁes not only the differences from adults but also
the level of supporting evidence, in order to encourage pediatric
asthma research and improve the management of asthma in 
children.
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IMPACT OF ADHERENCE TO INHALED CORTICOSTEROID ON
HEALTH CARE UTILIZATION
Park J, Ober J, Cantrell CR
GlaxoSmithKline, Research Triangle Park, NC, USA
OBJECTIVES: To evaluate the impact of adherence to inhaled
corticosteroids (ICS) on health care utilization in patients with
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asthma. METHODS: IHCIS managed care benchmark database
representing over 40 million US commercial lives was analyzed.
The ﬁrst prescription claim for an ICS in 2005 was identiﬁed
(index date) and patients who were continuously eligible for
medical and pharmacy services for 12 month before and after
the index date were included. Patients were selected based on the
following criteria using the 12 month pre-index date: 1) asthma-
related ER use or hospitalization >= 1, 2) asthma-related MD
visits >= 4, or 3) asthma-related medication ﬁlls >= 4 and diag-
nosis of asthma >= 1. Adherence was measured using both med-
ication possession ratio—MPR (adherence) and having at least
one ICS claim for each of the four post-index quarters (persis-
tence). Health care utilization including ER visits and hospital-
izations during the post 12 month period was compared between
the adherent and non-adherent groups. Poisson regression was
utilized to evaluate the impact of adherence with ICS on utiliza-
tion controlling for potential confounding factors. RESULTS: A
total of 18,420 patients 55.8% female with an average age of
31.68 met the criteria for ﬁnal analyses. Mean MPR was 0.43
and 12.7% of the study population had MPR >= 0.8 (adherent).
44.7% of patients ﬁlled at least one ICS prescription for four
consecutive quarters (persistent). Compared to non-adherent
patients, adherent patients had signiﬁcantly less incidence of hos-
pitalization or ER visit (IRR, 0.58; 95% CI, 0.37–0.89). Simi-
larly, persistence with ICS prescription ﬁlling behavior was
associated with a signiﬁcantly lower incidence of hospitalization
or ER visit (IRR, 0.74; 95% CI, 0.62–0.87). CONCLUSION:
Adherence with ICS was suboptimal in selected patients with
asthma. Regardless of metric used, patients identiﬁed as adher-
ent were less likely to have an asthma-related hospitalization or
ER visit.
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IS CURE WORSE THAN THE DISEASE?
Baser O
Thomson Medstat, Ann Arbor, MI, USA
OBJECTIVES: Instrumental variable approach gained popular-
ity in outcomes research because even in the presence of unmea-
sured confounding, such methods may consistently estimate the
average causal effects. However, for this consistent estimation to
be achieved several conditions must hold. Recent outcomes
research literature seems to ignore these conditions and the
results may provide inconsistent estimates. In this paper, we will
overview insturumental variable approach, as well as possible
tests to check the pre-requisite conditions and show how weak
instruments may produce inconsistents and inefﬁcient results.
METHODS: Recently proposed Swanson and Chao tests used
to check for weak instruments. For the cases with single endoge-
nous variables conditional likelihood ratio is implemented and
used. For the cases with more than one endogenous regressor
Anderson Rubin test is reviewed. Relevant level curve presented
for two endogeneous variables. RESULTS: The Market Scan
private insurance data base was used in this study which based
upon analytic sample of 36,341 asthma individuals whose health
care was provided under a variety of fee-for-service (FFS), fully
capitated and partially capitated health plans , including exclu-
sive provider organizations, indemnity plans. We showed how to
test weak insturements under the assumption that we have single
endogenous variables. We showed that one of the insturement
was weaked and the results produced inconsistent and inefﬁcient
estimates of the effect of treatment. With the correct instruments,
the estimates were statistically signiﬁcant (p = 0.001). CON-
CLUSION: Despite the obvious beneﬁt of instrumental variable
models, the method should not be used blindly. Several strong
conditions required for these models to work, and each of them
should be tested. Otherwise the results would be statatistically
worse than the results that can be achieved using simple ordi-
nary least squares.
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CAN PATIENTS WITH ASTHMA FEEL THEIR MAINTENANCE
INHALER WORKING RIGHT AWAY? REPRODUCIBILITY AND
VALIDITY OF A WEEKLY DIARY FOR ASSESSING PERCEPTION
AND SATISFACTION
Leidy N1, Patrick D2, Parasuraman B3, Petrillo J1, Mathias SD4
1United BioSource Corporation, Bethesda, MD, USA, 2University of
Washington, Seattle, WA, USA, 3AstraZeneca, Wilmington, DE, USA,
4Ovation Research Group a division of ICON Clinical Research, San
Francisco, CA, USA
OBJECTIVES: The ability of asthma patients to feel their main-
tenance inhaler work right away and their satisfaction with this
perception could serve as positive reinforcement of daily inhaler
therapy, leading to higher levels of persistence and improved
health status. This study examined the reliability and validity of
a 5-item weekly diary, the “Onset of Effect Questionnaire”
(OEQ), for describing patient perceptions associated with feeling
a maintenance therapy working right away as an initial step in
understanding this phenomenon. METHODS: Secondary analy-
ses of data from 360 patients (aged >18 yrs) with mild to mod-
erate asthma gathered during a Phase III, 12-week, randomized,
double-blind, double-dummy, placebo-controlled clinical trial
(SD-039-0716) comparing budesonide/formoterol pMDI with its
monoproducts. OEQ items were analyzed using dichotomous
scaling; the items identifying patients who perceived their med-
ication working right away (perception) and patients satisﬁed
with this perception (satisfaction) at Week1 were pre-speciﬁed as
primary outcomes. Statistical tests of reproducibility and valid-
ity were based on a comprehensive, a priori analysis plan.
RESULTS: One-week reproducibility: perception: phi = 0.77;
satisfaction: 0.70 (p < 0.0001). Construct validity: both perceiv-
ing and satisﬁed patients exhibited a higher increase in FEV1 15
minutes post-baseline than those who were not (p < 0.0001).
Those perceiving and satisﬁed patients also reported higher
symptom severity scores (Asthma Quality of Life Questionnaire)
than those who were not (p < 0.05; p < 0.01), with no differ-
ence in rescue medication use. Predictive: Patients perceiving and
those satisﬁed at Week 1 had higher 15 minute post-dose FEV1
(p < 0.0001) and greater satisfaction with medication (Overall
Perception of Medication subscale of the Patient Satisfaction
with Asthma Medication (PSAM) questionnaire) and asthma
relief (PSAM Relief subscale) at the end of Week 2 than patients
who did not (p < 0.0001). CONCLUSION: The weekly diary
approach is a reliable and valid method for identifying patients
who perceive their medication working right away and those sat-
isﬁed with this perception.
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UNDERSTANDING PATIENT PERCEPTION OF THERAPY:
DEVELOPMENT OF A WEEKLY DIARY TO DETERMINE
WHETHER PATIENTS WITH ASTHMA CAN FEEL THEIR
MAINTENANCE INHALER WORKING RIGHT AWAY
Mathias SD1, Parasuraman B2, Petrillo J3, Leidy NK3
1Ovation Research Group a division of ICON Clinical Research, San
Francisco, CA, USA, 2AstraZeneca, Wilmington, DE, USA, 3United
BioSource Corporation, Bethesda, MD, USA
OBJECTIVES: The inﬂuence of positive reinforcement on behav-
ior is well documented, beginning with the original work by B.F.
Skinner to more recent evidence showing its value in improving
treatment adherence. An important challenge in the asthma pop-
ulation is persistence with daily maintenance therapy. Immedi-
